CN Stock MarketDetailed Quotes
301367 BMC Medical
- 75.51
- -2.59-3.32%
Market Closed Oct 15 15:00 CST
6.77BMarket Cap46.30P/E (TTM)
79.28High75.16Low19.85KlotVolume78.06Open78.10Pre Close152.68MTurnover3.51%Turnover Ratio22.75P/E (Static)89.60MShares95.7552wk High2.42P/B4.27BFloat Cap50.3652wk Low93.72Limit Up56.52MShs Float236.34Historical High62.48Limit Down5.28%Amplitude50.36Historical Low0.71Dividend TTM76.93Avg Price8.73KlotAsk0.95%Div YieldTTM100Lot Size9.77KlotBid
BMC Medical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -35.64%437.8M | -43.90%220.11M | -27.17%1.07B | -12.09%853.23M | 18.26%680.22M | 85.38%392.37M | 110.91%1.46B | 105.52%970.62M | 97.66%575.21M | --211.65M |
| Refunds of taxes and levies | -96.50%3.61M | ---- | -34.18%118.16M | 32.18%122.37M | 79.23%103.18M | 252.43%40.98M | 257.04%179.51M | 153.66%92.58M | 160.90%57.57M | --11.63M |
| Net deposit increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in borrowings from central bank | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in placements from other financial institutions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received from interests, fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in repurchase business capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Premiums received from original insurance contracts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net cash received from reinsurance business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in deposits from policyholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in funds disbursed | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net cash received from trading securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received relating to other operating activities | 8.60%11.02M | 90.91%4.9M | 48.31%19.36M | 260.08%16.01M | 139.62%10.15M | 1,437.87%2.57M | -76.60%13.06M | -43.73%4.45M | -39.40%4.24M | --167.03K |
| Cash inflows from operating activities | -42.99%452.44M | -48.38%225.01M | -27.34%1.2B | -7.12%991.62M | 24.57%793.54M | 95.09%435.92M | 107.01%1.66B | 106.64%1.07B | 99.03%637.01M | --223.45M |
| Goods services cash paid | -62.94%153.23M | -69.42%67.36M | -34.54%614.75M | -8.17%543.38M | 23.63%413.53M | 78.46%220.26M | 119.63%939.11M | 100.04%591.75M | 132.94%334.49M | --123.42M |
| Staff behalf paid | -5.09%97.99M | -14.78%55.07M | 30.75%180.24M | 39.91%141.98M | 49.83%103.25M | 58.30%64.63M | 37.58%137.85M | 26.32%101.48M | 24.55%68.91M | --40.82M |
| All taxes paid | -73.41%25.61M | -89.69%5.42M | 10.50%112.37M | 69.60%110.23M | 313.03%96.3M | 695.53%52.54M | 93.67%101.69M | 37.80%65M | -9.37%23.31M | --6.6M |
| Net loan and advance increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net deposit in central bank and institutions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net lend capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid for fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid for indemnity of original insurance contract | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Policy dividend cash paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid relating to other operating activities | 9.23%59.52M | -3.41%21.49M | 41.64%145.07M | -11.98%104.46M | 83.56%54.5M | 91.52%22.25M | -11.24%102.42M | 105.64%118.68M | -1.91%29.69M | --11.62M |
| Cash outflows from operating activities | -49.61%336.36M | -58.48%149.34M | -17.85%1.05B | 2.64%900.05M | 46.27%667.56M | 97.12%359.68M | 84.14%1.28B | 82.30%876.9M | 79.05%456.4M | --182.47M |
| Net cash flows from operating activities | -7.86%116.08M | -0.74%75.68M | -59.73%151.11M | -51.99%91.57M | -30.25%125.98M | 86.04%76.24M | 259.39%375.21M | 434.97%190.75M | 177.23%180.61M | 721.14%40.98M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -7.85%3.42B | -7.37%1.46B | 417.29%7.11B | 384.06%4.86B | 488.95%3.71B | 465.11%1.57B | 55.65%1.37B | 56.44%1B | 63.73%630.2M | --278M |
| Cash received from returns on investments | -13.94%26.06M | -39.93%6.4M | 438.74%57.43M | 392.80%40.2M | 402.48%30.28M | 352.64%10.66M | 73.34%10.66M | 78.04%8.16M | 146.79%6.03M | --2.35M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 164.24%449.21K | 39.84%180K | 106.26%160.88K | 466.67%170K | 219.22%170K | --128.72K | 10,681.52%78K | 1,400.00%30K | 2,562.72%53.25K | --0 |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | --5.86M | ---- | ---- | --0 |
| Cash inflows from investing activities | -7.89%3.45B | -7.59%1.46B | 415.26%7.17B | 384.13%4.9B | 488.11%3.74B | 464.21%1.58B | 56.44%1.39B | 56.60%1.01B | 64.27%636.28M | --280.35M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -40.89%7.51M | -45.31%3.06M | 1.59%24.12M | 10.93%18.6M | 69.67%12.71M | 256.50%5.6M | 136.88%23.75M | 95.34%16.77M | 210.40%7.49M | --1.57M |
| Cash paid to acquire investments | -1.34%3.65B | 7.08%1.81B | 110.92%6.84B | 331.31%4.79B | 461.91%3.7B | 479.16%1.69B | 207.72%3.24B | 44.37%1.11B | 23.70%659.2M | --291.2M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Impawned loan net increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash outflows from investing activities | -1.48%3.66B | 6.91%1.81B | 110.12%6.86B | 326.54%4.81B | 457.51%3.72B | 477.96%1.69B | 207.06%3.27B | 44.93%1.13B | 24.54%666.69M | --292.77M |
| Net cash flows from investing activities | -955.54%-215.32M | -214.77%-347.23M | 116.09%301.9M | 182.98%94.96M | 182.76%25.17M | -788.47%-110.31M | -972.80%-1.88B | 12.65%-114.43M | 79.45%-30.41M | 87.01%-12.42M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | --1.76B | ---- | ---- | --0 |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash from borrowing | --30M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash inflows from financing activities | --30M | ---- | ---- | ---- | ---- | ---- | --1.76B | ---- | ---- | --0 |
| Borrowing repayment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Dividend interest payment | -52.04%62.16M | ---- | --130M | --130M | --129.6M | ---- | ---- | ---- | ---- | --0 |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | --2M | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash payments relating to other financing activities | 384.12%15.71M | -10.23%1.78M | -66.32%9.76M | 407.50%4.4M | 297.45%3.24M | 558.23%1.98M | 2,000.17%28.99M | -19.77%866.99K | 21.97%816.32K | --300.97K |
| Cash outflows from financing activities | -41.38%77.87M | -10.23%1.78M | 382.18%139.76M | 15,401.92%134.4M | 16,173.60%132.84M | 558.23%1.98M | -3.96%28.99M | -96.81%866.99K | -97.23%816.32K | --300.97K |
| Net cash flows from financing activities | 63.97%-47.87M | 10.23%-1.78M | -108.05%-139.76M | -15,401.92%-134.4M | -16,173.60%-132.84M | -558.23%-1.98M | 5,849.29%1.74B | 96.81%-866.99K | 97.23%-816.32K | ---300.97K |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 281.20%2.41M | 130.79%896.85K | -105.36%-406.96K | -118.36%-1.3M | -132.20%-1.33M | -402.26%-2.91M | 306.74%7.59M | 671.81%7.07M | 502.14%4.14M | ---579.99K |
| Net increase in cash and cash equivalents | -952.61%-144.7M | -599.16%-272.43M | 29.33%312.84M | -38.40%50.83M | -88.95%16.97M | -240.75%-38.97M | 331.86%241.89M | 166.68%82.51M | 235.47%153.52M | 130.41%27.68M |
| Add:Begin period cash and cash equivalents | 87.92%668.67M | 87.77%668.67M | 212.29%355.83M | 212.29%355.83M | 212.29%355.83M | 212.54%356.11M | -47.80%113.94M | -47.80%113.94M | -47.80%113.94M | --113.94M |
| End period cash equivalent | 40.55%523.97M | 24.94%396.23M | 87.92%668.67M | 107.00%406.66M | 39.39%372.8M | 123.93%317.15M | 212.29%355.83M | 107.85%196.46M | 154.86%267.46M | --141.63M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data